Back story here.Amgen on Friday said that a federal court has denied Roche's motion to dismiss Amgen's patent infringement lawsuit against Roche.
The court also denied a motion by Ortho Biotech Products L.P. to intervene as a co-plaintiff in the case, the Thousand Oaks, California-based biotechnology company said.
Amgen said it continues to believe that Roche's peg-EPO product violates Amgen's patents, and doesn't provide any clinical or patient benefit over Amgen's innovative therapies, Epogen and Aranesp.
No comments:
Post a Comment